Decaprenylphosphoryl-&bgr;-D-Ribose 2'-Epimerase from Mycobacterium tuberculosis is a Magic Drug Target

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|17|27|3099-3108

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.17, Iss.27, 2010-09, pp. : 3099-3108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Type 1 11 &bgr;-hydroxysteroid Dehydrogenase as Universal Drug Target in Metabolic Diseases?

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 3, 2006-09 ,pp. : 259-269

Bentham Science Publishers

Access to resources Recommend Favorite

Purine Metabolism in Mycobacterium tuberculosis as a Target for Drug Development

By  

Current Pharmaceutical Design, Vol. 13, Iss. 6, 2007-02 ,pp. : 599-608

Bentham Science Publishers

Access to resources Recommend Favorite

Mycobacterium tuberculosis DNA Gyrase as a Target for Drug Discovery

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 7, Iss. 2, 2007-01 ,pp. : 159-168

Bentham Science Publishers

Access to resources Recommend Favorite

Evolution of Drug Resistance: Insight on TEM &bgr;-Lactamases Structure and Activity and &bgr;-Lactam Antibiotics

By  

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 2, 2014-02 ,pp. : 111-122

Bentham Science Publishers

Access to resources Recommend Favorite

Transforming Growth Factor-&bgr;: A Molecular Target for the Future Therapy of Glioblastoma

By  

Current Pharmaceutical Design, Vol. 12, Iss. 3, 2006-01 ,pp. : 341-349

Bentham Science Publishers

Access to resources Recommend Favorite